Dr Doug Brown, director of research and development at the Alzheimer’s Society which helped fund the research along with Alzheimer’s Research UK, echoed Dr Sims’s optimism.
“Over 60 per cent of people with dementia have Alzheimer’s illness, yet despite its prevalence we still don’t fully understand the complex causes of the illness,” he said.
The “exciting” discovery that two genes are linked to Alzheimer’s could lead to a way of treating the devastating and currently incurable illness, scientists believe.
“There’s no cure for Alzheimer’s illness, but medication is available that can help relieve some of the symptoms and slow down the progression of the condition in some people,” it says.
All of the other genes we have highlighted … affect the risk of Alzheimer’s illness but how they work is very unclear.”Unlike other genes know to affect Alzheimer’s, these two, PLCG2 and ABI3, were found to cause changes in proteins involved in the illness.
investigators find new early clues pointing to onset of Alzheimer’s illness
July 17 (UPI) — A study by a team of researchers at Cardiff University has identified two new genes that can influence the risk of developing Alzheimer’s disease.
In Britain, there are currently 850,000 people living with Alzheimer’s disease.
Insights like this are vital to help unravel the complexities of Alzheimer’s disease and show researchers where to focus their efforts in the search for new, effective treatments.”
The study, published July 17 in Nature Genetics, compared the DNA of tens of thousands of individuals with Alzheimer’s disease with age-matched controls.
“Over 60 percent of people with dementia have Alzheimer’s disease, yet despite its prevalence we still don’t fully understand the complex causes of the disease,” said Dr. Doug Brown, director of Research and Development at the Alzheimer’s Society.